NCT00440804View on ClinicalTrials.gov

Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2002

Study Completion Date

August 31, 2005

Conditions
Patent Ductus Arteriosus
Interventions
DRUG

ibuprofen l-lysine iv solution (NeoProfen (R) )

Sponsors

Lead Sponsor

Farmacon
All Listed Sponsors
lead

Farmacon

INDUSTRY